Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-09-06
2005-09-06
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S453000, C514S456000, C514S824000, C514S400000, C514S04400A, C514S474000, C514S050000, C514S018700, C514S251000, C514S423000, C514S440000, C514S458000, C424S283100, C424S729000, C424S401000, C536S023400, C536S024300, C536S023100, C536S023200, C536S023500, C435S006120, C435S069100
Reexamination Certificate
active
06939860
ABSTRACT:
The present invention relates to a composition comprising a catechin compound, ascorbic acid, proline and lysine. The present invention also relates to a method for treating neoplastic disease using a composition comprising a catechin compound, ascorbic acid, proline and lysine.
REFERENCES:
patent: 5962517 (1999-10-01), Murad
patent: WO 00/76492 (2000-12-01), None
Demeule et al.,“Matrix metalloproteinase inhibition by green tea catechins”, Biochimica et Biophysica Acta, vol. 1478, pp. 51-60,2000.
International Search Report for International Application No. PCT/EP02/01005.
Stoner, D. G. et al., “Polyphenols as Cancer Chemopreventive Agents”, Journal of Cellular Biochemistry, vol. 22, pp. 169-180, (1995).
Demeule, M. et al., “Matrix Metalloproteinase inhibition by green tea catechins”, Biochimica et Biophysica Acta, vol. 1478, pp. 51-60, (2000).
Zhao, J.F. et al., “Green Tea Protects Against Psoralen Plus Ultraviolet A-Induced Photochemical damage to Skin”, The Journal of Investigative Dermatology, vol. 113, No. 6, pp. 1070-1075, (1999).
Horie, H. et al., “Simultaneous determination of qualitatively important components in green tea infusions using capillary electrophoresis”, Journal of Chromatography A., vol. 758, pp. 332-335, (1997).
Mukhtar, H. et al., “Tea polyphenois: prevention of cancer and optimizing health1.3”, American Society for Clinical Nutrition, vol. 71, pp. 1698S-1702S, (2000).
Ahmad, N. et al., “Green Tea Constituent Epigallocatechin-3-Gallate and Induction of Apoptosis and Cell Cycle Arrest in Human Carcinoma Cells”, Journal of the National Cancer Institute, vol. 89, No. 24, pp. 1881-1886, (1997).
Sadzuka, Y. et al., “Modulation of cancer chemotherapy by green tea” Clin Cancer Res, vol. 4, No. 1, (1998).
Cao, Y. et al., “Angiogenesis inhibited by drinking tea” Nature, vol. 398, p. 381 (1999).
Jankun, J. et al., “Why drinking green tea could prevent cancer” Nature vol. 387, p. 561, (1997).
Chen, L. et al., “Absorption, Distribution, and Elimination of Tea Polyphenols in Rats” The American Society for Pharmacology and Experimental Therapeutics, vol. 25, No. 9, pp. 1045-1049 (1997).
Yang, C.S. et al., “Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers” Laboratory for Cancer Research, vol. 7, No. 4, (1998).
Bell, J. RC. et al., “(+)-Catechin in human plasma after ingestion of a single serving of reconstituted red wine1,2,3”, American Journal of Clinical Nutrition, vol. 71, No. 1, pp. 103-108 (2000).
Sherry Chow, H-H. et al., “Phase 1 Pharmacokinetic Study of Tea Polyphenols following Single-dose Administration of Epigallocatechin Gallate and Polyphenon E1”, Cancer Epidemiology, Biomarkers & Prevention, vol. 10, pp. 53-58, (2001).
Ivanov Vadim
Netke Shriran
Niedzwiecki Aleksandra
Rath Matthias
Roomi Wahid M.
Kenyon & Kenyon
Khare Devesh
Peselev Elli
Rath Matthias
LandOfFree
Composition and method for treatment of neoplastic diseases... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method for treatment of neoplastic diseases..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for treatment of neoplastic diseases... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3416304